Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3.45M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
7.1M
-
Shares change
-
-1.09M
-
Total reported value, excl. options
-
$6.01M
-
Value change
-
-$1.01M
-
Number of buys
-
10
-
Number of sells
-
-14
-
Price
-
$0.85
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) as of Q2 2024
33 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 par value per share as of Q2 2024.
IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.1M shares
.
Largest 10 shareholders include AIGH Capital Management LLC (2.13M shares), VANGUARD GROUP INC (1.42M shares), Ensign Peak Advisors, Inc (1.12M shares), Sigma Planning Corp (600K shares), 683 Capital Management, LLC (591K shares), GEODE CAPITAL MANAGEMENT, LLC (317K shares), Stonegate Investment Group, LLC (180K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (103K shares), Voss Capital, LP (91K shares), and STATE STREET CORP (88.7K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.